AMZN
Amazon.com, Inc.
AMZN has the edge over ARKO overall, supported by stronger valuation and stronger modeled upside.
ARKO
Arko Corp.
ARKO trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ARKO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
ARKO's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ARKO in the historical PE scenario, which offers more potential upside but is not a forecast.
ARKO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $0.99 | -76% |
| Fair | 28x | $1.70 | -59% |
| Forward | 29x | $4.10 | — |
| Expensive | 62x | $3.70 | -9.9% |
| Current | 68x | $4.10 | — |
Historical ranges are pointers, not guarantees.
ARKO's PE is in its expensive range at 68x. If earnings grow as analysts expect, today's price would be 29x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ARKO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect ARKO's earnings to grow, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ARKO on earnings, with more consistent year-over-year improvement.
ARKO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.14 | +133% |
| Q3 2026 | $0.06 | -45% |
| Q2 2026 | $0.08 | 0% |
| Q1 2026 | $0.20 | +567% |
| Q4 2025 | $0.15 | +15% |
| Q3 2025 | $0.11 | -27% |
| Q2 2025 | $0.08 | -68% |
| Q1 2025 | $0.03 | -88% |
| Q4 2024 | $0.13 | -46% |
ARKO's earnings per share have fallen from their peak: $0.06 over the past year, against $0.60 in mid-2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ARKO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ARKO on profitability, with a higher operating margin.
ARKO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.4B | +18% |
| Q2 2026 | $2.3B | +17% |
| Q1 2026 | $1.8B | -3.1% |
| Q4 2025 | $1.8B | -9.9% |
| Q3 2025 | $2B | -11% |
| Q2 2025 | $2B | -16% |
| Q1 2025 | $1.8B | -12% |
| Q4 2024 | $2B | -11% |
ARKO's revenue is growing: $2.4B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | -0.3 points |
| Q2 2026 | 1.3% | -1.5 points |
| Q1 2026 | 0.6% | +1.2 points |
| Q4 2025 | 1.2% | +0.5 points |
| Q3 2025 | 1.8% | 0 points |
| Q2 2025 | 2.8% | +1 points |
| Q1 2025 | -0.6% | -0.4 points |
| Q4 2024 | 0.7% | -0.4 points |
ARKO's operating margin was 1.5% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ARKO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.5M | -147% |
| Q2 2026 | $8.9M | -9.5% |
| Q1 2026 | -$11.6M | -173% |
| Q4 2025 | $14.9M | +$28.3M |
| Q3 2025 | $24.5M | -69% |
| Q2 2025 | $9.8M | -83% |
| Q1 2025 | $16M | +$32.5M |
| Q4 2024 | -$13.4M | -162% |
ARKO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ARKO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -36K shares |
| 1 year | +0.6% | +644K shares |
| 3 years | -3.7% | -4.4M shares |
| 5 years | -13% | -18.1M shares |
| Available history | -74% | -326M shares |
ARKO has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $51,000 |
| Q2 2026 | $212,000 |
| Q1 2026 | $4.3M |
| Q4 2025 | $7.2M |
| Q3 2025 | $4.2M |
| Q2 2025 | $9.2M |
| Q1 2025 | $7.4M |
| Q4 2024 | — |
ARKO spent $12M buying back its own shares over the past year, down 43% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over ARKO on leverage, with a lower net debt burden relative to earnings.
ARKO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.7x | Moderate |
ARKO's net debt is about 1.9 years of its operating earnings (EBITDA), down from 2.6 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ARKO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.4 | Neutral |
| Stochastic | 12.4 | Oversold |
ARKO's weekly RSI is 36 (neutral) and its Stochastic is 12 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over ARKO on valuation relative to its sector.
ARKO PE vs Consumer Cyclical Sector
| Metric | ARKO | Sector median | Relative |
|---|---|---|---|
| PE | 68x | 18x | 279% above |
| PE % | 85 | 47 | 38 pts above |
ARKO is trading at 68x earnings, a 279% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over ARKO on trend strength, trading above more of its moving averages.
ARKO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.04 | 1.5% above |
| 20 week MA | $5.28 | 22% below |
| 50 week MA | $5.78 | 29% below |
| 100 week MA | $5.35 | 23% below |
| 200 week MA | $6.27 | 35% below |
ARKO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 35% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ARKO on returns for 2026, with the stronger performance.
ARKO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.0 | $9.44 | -5.9% |
| 2021 | $9.44 | $8.52 | -9.7% |
| 2022 | $8.52 | $8.62 | +1.2% |
| 2023 | $8.62 | $8.25 | -4.3% |
| 2024 | $8.25 | $6.53 | -21% |
| 2025 | $6.53 | $4.64 | -29% |
| 2026 YTD | $4.64 | $4.10 | -12% |
ARKO has finished three years in a row lower, and it's down 12% so far in 2026.